Announcement on Receipt of Approval Notice for Drug Supplementary Application
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600513)"Jiangsu Lianhuan Pharmaceutical Co., Ltd."Announcement on Receipt of Approval Notice for Drug Supplementary Application
Filed with SSE · Stock code 600513 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Jiangsu Lianhuan Pharmaceutical Co., Ltd. on 6ix
Story so far
Earlier from Jiangsu Lianhuan Pharmaceutical
- Announcement on Outline of the 2026 Semi-annual Performance Briefing
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Semi-annual Report for 2026
- Announcement on the Addition of a Related Party Not Under Common Control and Increase of the Estimated Amount of Routine Related Party Transactions for 2026
Follow Jiangsu Lianhuan Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Lianhuan Pharmaceutical